Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 2/20 | 0.36 |
| ▸ | RXRB | P28702 | 2/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.34 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.34 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10129307 | 0.94 | HPGD (0.40) | HPGDMAPTTSHRRXRARXRB | |
| SCHEMBL10129322 | 0.90 | HPGD (0.38) | HPGDMAPTTSHRRXRARXRB | |
| SCHEMBL10112618 | 0.86 | ALDH1A1 (0.41) | HPGDMAPTPTGER4HDAC4CYP1A2 | |
| SCHEMBL10129760 | 0.86 | HPGD (0.47) | HPGDMAPTTSHRRXRARXRB | |
| SCHEMBL10112613 | 0.83 | RORC (0.43) | MAPTPTGER4PTPN1HDAC4CYP1A2 | |
| SCHEMBL10112628 | 0.83 | EDNRA (0.39) | HPGDMAPTTSHRCYP1A2CYP2D6 | |
| SCHEMBL10129313 | 0.83 | HPGD (0.46) | HPGDMAPTTSHRRXRARXRB | |
| SCHEMBL8406187 | 0.82 | L3MBTL1 (0.41) | MAPTHDAC4RORCKDM4EALDH1A1 | |
| SCHEMBL8406178 | 0.82 | L3MBTL1 (0.42) | MAPTPTPN1HDAC4RORCKDM4E | |
| SCHEMBL13209233 | 0.81 | KDM4E (0.38) | MAPTHDAC4AKR1C4AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110980-B2 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| EP-1918350-B1 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LAB (JP) | 2010-08-11 | — | — | EP | disclosed |
| US-20100164376-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-07-01 | — | — | US | disclosed |
| US-7674914-B2 | novel anthracene derivative represented by General Formula (1) is provided, which enables the production of a light-emitting element with high luminous efficiency and a long lifetime. A high-performance light-emitting device and electronic device in which the anthracene derivative light emitting diode | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-03-09 | — | — | US | disclosed |
| EP-1918350-A2 | Anthracene derivative, and light emitting element, light emitting device, electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103315-A1 | Anthracene Derivative, and Light Emitting Element, Light Emitting Device, Electronic Device Using Anthracene Derivative | AMY1A, CYP1A1, CRY1 | HPGD 372/4885MAPT 4092/4885TSHR 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.